플라즈마 분획 시장 보고서(2026년)

Plasma fractionation refers to a process that combines multiple manufacturing steps to separate crude plasma fractions, which are then sequentially and systematically refined into specific therapeutic products in an integrated manner.

The primary products in the plasma fractionation market include immunoglobulins, coagulation factors, albumin, and protease inhibitors. Immunoglobulins are used in the treatment of a broad range of conditions, such as primary and secondary immunodeficiencies, autoimmune disorders, and inflammatory diseases. Immunoglobulins (Ig), also known as antibodies, are glycoproteins produced by plasma cells that play a vital role in the immune system by identifying and neutralizing foreign substances, including pathogenic bacteria and viruses. These products are applied across areas such as immunology, hematology, neurology, critical care, hemato-oncology, and rheumatology, and are utilized by end users including hospitals and clinics, clinical research laboratories, and academic institutions.

Tariffs have introduced challenges for the plasma fractionation market by increasing import costs for raw plasma and specialized manufacturing equipment, affecting production efficiency. Segments such as immunoglobulins and coagulation factors are most impacted, particularly in regions like Europe and Asia-Pacific where plasma imports are significant. However, tariffs have also encouraged local production and investments in domestic plasma fractionation facilities, potentially fostering self-sufficiency and innovation within the market.

The plasma fractionation market research report is one of a series of new reports from The Business Research Company that provides plasma fractionation market statistics, including plasma fractionation industry global market size, regional shares, competitors with a plasma fractionation market share, detailed plasma fractionation market segments, market trends and opportunities, and any further data you may need to thrive in the plasma fractionation industry. This plasma fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plasma fractionation market size has grown rapidly in recent years. It will grow from $34.14 billion in 2025 to $37.63 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growth in demand for immunoglobulins, increased prevalence of hematological disorders, technological advancements in plasma fractionation, expansion of hospital and clinical infrastructure, rise in awareness about plasma-derived therapies.

The plasma fractionation market size is expected to see rapid growth in the next few years. It will grow to $55.85 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing adoption of precision medicine, integration of ai in plasma manufacturing, expansion of global biopharmaceutical collaborations, rising investments in plasma collection centers, development of novel plasma-derived therapies. Major trends in the forecast period include advanced plasma fractionation techniques, biopharmaceutical product diversification, enhanced quality control and regulatory compliance, expansion of contract manufacturing organizations (cmos/cdmos), supply chain optimization in plasma products.

The growing prevalence of chronic diseases is expected to drive the expansion of the plasma fractionation market in the coming years. Chronic diseases are conditions that persist for one year or longer and require continuous medical care, with common examples including heart disease, cancer, and diabetes. Treating patients with chronic conditions through access to plasma-derived products helps reduce morbidity, enhance quality of life, and offers a cost-effective therapeutic approach, thereby increasing demand for plasma fractionation. For instance, in March 2025, according to GOV.UK, a UK-based government organization, the prevalence of GP-recorded type 2 diabetes among adults aged 17 and above in England reached 7.0% in March 2024, rising from 6.8% in March 2023. Therefore, the increasing burden of chronic diseases across all age groups is expected to propel the growth of the plasma fractionation market.

Major companies operating in the market are adopting advanced technologies, such as high-tech facility processes, to convert donated human plasma into essential medicines while improving efficiency and safety. For instance, in March 2023, CSL Behring, a Germany-based company, inaugurated a new plasma fractionation facility valued at $470 million that incorporates state-of-the-art technology to enhance the efficiency and safety of plasma processing, resulting in higher-quality and more dependable medicines. By expanding the supply of these critical therapies, the facility supports the rising demand and helps ensure that a greater number of patients can access life-saving treatments. The use of advanced automation and self-cleaning systems minimizes contamination risks and improves overall hygienic conditions, thereby strengthening patient safety.

In May 2024, LFB, a France-based biopharmaceutical company, acquired Amber Plasma for an undisclosed amount. Through this acquisition, LFB seeks to strengthen its plasma collection network across Europe and expand its capacity to support the manufacturing of plasma-derived therapies. Amber Plasma is a Czech Republic-based company specializing in plasma collection.

Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plasma fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plasma fractionation market includes revenues earned by entities by combining manufacturing steps to isolate, in a sequential and integrated manner. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Fractionation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses plasma fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The plasma fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Immunoglobulins; Coagulation Factors; Albumin; Protease Inhibitors
• 2) By Application: Immunology; Hematology; Neurology; Critical Care; Hemato-Oncology; Rheumatology
• 3) By End User: Hospitals and Clinics; Clinical Research Laboratories; Academic Institutes
• Subsegments:
• 1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
• 2) By Coagulation Factors: Factor VIII; Factor IX; Prothrombin Complex Concentrates (PCC)
• 3) By Albumin: Human Albumin; Bovine Serum Albumin (BSA)
• 4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT); C1 Esterase Inhibitor (C1-INH)
• Companies Mentioned: Baxter International Inc.; Bio Products Laboratory Limited; Biotest AG; CSL Limited; Grifols S. A; ADMA Biologics Inc.; Green Cross Corporation; Hualan Bioengineering Inc.; Intas Pharmaceuticals Ltd.; Japan Blood Products Organization; Kedrion S. P. A.; Kamada Ltd.; LFB Biomedicaments S. A. S; Octapharma AG; Sanquin Plasma Products B. V.; Shanghai Raas Blood Products Co. Ltd.; Takeda Pharmaceutical Company; Terumo BCT; China Biologic Products Holdings Inc.; China National Biotec Group; Emergent BioSolutions Inc.; Bharat Serum Vaccines Limited; Plasma Therapeutics; Prothya Biosolutions B. V.; BioPharma Plasma LLC; BioLife Plasma Services LP
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Plasma Fractionation Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Plasma Fractionation Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Plasma Fractionation Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Plasma Fractionation Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Advanced Plasma Fractionation Techniques
  • 4.2.2 Biopharmaceutical Product Diversification
  • 4.2.3 Enhanced Quality Control And Regulatory Compliance
  • 4.2.4 Expansion Of Contract Manufacturing Organizations (Cmos/Cdmos)
  • 4.2.5 Supply Chain Optimization In Plasma Products

5. Plasma Fractionation Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Clinical Research Laboratories
• 5.3 Academic Institutes
• 5.4 Blood And Plasma Banks
• 5.5 Pharmaceutical Companies

6. Plasma Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Plasma Fractionation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Plasma Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Plasma Fractionation Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Plasma Fractionation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Plasma Fractionation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Plasma Fractionation Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Plasma Fractionation Market Segmentation

• 9.1. Global Plasma Fractionation Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
• 9.2. Global Plasma Fractionation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
• 9.3. Global Plasma Fractionation Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes
• 9.4. Global Plasma Fractionation Market, Sub-Segmentation Of Immunoglobulins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
• 9.5. Global Plasma Fractionation Market, Sub-Segmentation Of Coagulation Factors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC)
• 9.6. Global Plasma Fractionation Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Human Albumin, Bovine Serum Albumin (BSA)
• 9.7. Global Plasma Fractionation Market, Sub-Segmentation Of Protease Inhibitors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH)

10. Plasma Fractionation Market Regional And Country Analysis

• 10.1. Global Plasma Fractionation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Plasma Fractionation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Plasma Fractionation Market

• 11.1. Asia-Pacific Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Plasma Fractionation Market

• 12.1. China Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Plasma Fractionation Market

• 13.1. India Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Plasma Fractionation Market

• 14.1. Japan Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Plasma Fractionation Market

• 15.1. Australia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Plasma Fractionation Market

• 16.1. Indonesia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Plasma Fractionation Market

• 17.1. South Korea Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Plasma Fractionation Market

• 18.1. Taiwan Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Plasma Fractionation Market

• 19.1. South East Asia Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Plasma Fractionation Market

• 20.1. Western Europe Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Plasma Fractionation Market

• 21.1. UK Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Plasma Fractionation Market

• 22.1. Germany Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Plasma Fractionation Market

• 23.1. France Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Plasma Fractionation Market

• 24.1. Italy Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Plasma Fractionation Market

• 25.1. Spain Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Plasma Fractionation Market

• 26.1. Eastern Europe Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Plasma Fractionation Market

• 27.1. Russia Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Plasma Fractionation Market

• 28.1. North America Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Plasma Fractionation Market

• 29.1. USA Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Plasma Fractionation Market

• 30.1. Canada Plasma Fractionation Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Plasma Fractionation Market

• 31.1. South America Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Plasma Fractionation Market

• 32.1. Brazil Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Plasma Fractionation Market

• 33.1. Middle East Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Plasma Fractionation Market

• 34.1. Africa Plasma Fractionation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Plasma Fractionation Market, Segmentation By Product, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Plasma Fractionation Market Regulatory and Investment Landscape

36. Plasma Fractionation Market Competitive Landscape And Company Profiles

• 36.1. Plasma Fractionation Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Plasma Fractionation Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Plasma Fractionation Market Company Profiles
  • 36.3.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Bio Products Laboratory Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. CSL Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Grifols S. A Overview, Products and Services, Strategy and Financial Analysis

37. Plasma Fractionation Market Other Major And Innovative Companies

• ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group

38. Global Plasma Fractionation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Plasma Fractionation Market

40. Plasma Fractionation Market High Potential Countries, Segments and Strategies

• 40.1 Plasma Fractionation Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Plasma Fractionation Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Plasma Fractionation Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer